Thein vitroantibacterial and antibiofilm activity of chlorogenic acid against clinical isolates ofStenotrophomonas maltophiliawas investigated through disk diffusion, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), time-kill and biofilm assays. A total of 9 clinicalS. maltophiliaisolates including one isolate resistant to trimethoprim/sulfamethoxazole (TMP/SMX) were tested. The inhibition zone sizes for the isolates ranged from 17 to 29 mm, while the MIC and MBC values ranged from 8 to 16 μg mL−1and 16 to 32 μg mL−1. Chlorogenic acid appeared to be strongly bactericidal at 4x MIC, with a 2-log reduction in viable bacteria at 10 h.In vitroantibiofilm testing showed a 4-fold reduction in biofilm viability at 4x MIC compared to 1x MIC values (A 490 nm) of chlorogenic acid. The data from this study support the notion that the chlorogenic acid has promisingin vitroantibacterial and antibiofilm activities againstS. maltophilia.
Curcumin has been found to possess significant pharmaceutical activities. However, owing to its low bioavailability, there is a limitation of employing it towards clinical application. In an attempt to surmount this implication, often the choice is designing novel drug delivery systems. Herein, sterically stabilized nanoscale dispersion loaded with curcumin (nanodispersion) based on non-ionic colloidal system has been proposed. In this study, the process conditions were effectively optimized using response surface methodology (RSM) with Box–Behnken design (BBD). The suggested optimum formulation proved to be an excellent fit to the actual experimental output. STEM images illustrate that the optimal curcumin-loaded nanodispersion has spherical morphology with narrow particle size distribution. Particle size distribution study confirms that the solution pH does not affect the nanodispersion, and physical stability study shows that the colloidal system is stable over 90 days of storage at ambient conditions. More importantly, controlled release profile was achieved over 72 h and the in vitro drug release data fit well to Higuchi model (R2=0.9654).
1 November 2013 in Journal of Medical Microbiology
In pathological conditions with concurrent neutrophilia, modifications of erythrocyte membrane proteins are reported. In chronic myeloid leukemia (CML), a myeloproliferative disease wherein neutrophilia is accompanied by enhanced erythrophagocytosis, we report for the first time excessive cleavage of erythrocyte band 3. Distinct fragments of band 3 serve as senescent cell antigens leading to erythrophagocytosis. Using immunoproteomics, we report the identification of immunogenic 43 kDa fragment of band 3 in 68% of CML samples compared to their detection in only 38% of healthy individuals. Thus, excessive fragmentation of band 3 in CML, detected in our study, corroborated with the eryptotic phenotype. We demonstrate the role of neutrophilic cathepsin G, detected as an immunogen on erythrocyte membrane, in band 3 cleavage. Cathepsin G from serum adsorbs to the erythrocyte membrane to mediate cleavage of band 3 and therefore contribute to the eryptotic phenotype in CML.